| Daniel Getts |
dge***@myeloidtx.com
|
myeloidtx.com |
Chief Executive Officer & Co-Founder |
|
Boston, MA, US |
|
| Michele Gerber |
mge****@myeloidtx.com
|
myeloidtx.com |
Chief Medical Officer |
|
Ann Arbor, MI, US |
|
| Jerome CHAL |
jch**@myeloidtx.com
|
myeloidtx.com |
VP, Head of CMC |
|
Boston, MA, US |
|
| Thomas Prod'homme |
tpr********@myeloidtx.com
|
myeloidtx.com |
Vice President, Translational Research |
|
Boston, Massachusetts, United States |
|
| Kenanova Vania |
kva***@myeloidtx.com
|
myeloidtx.com |
Senior Director - Antibody Discovery and Engineering |
|
Cambridge, MA, US |
|
| Shannon Argueta |
sar*****@myeloidtx.com
|
myeloidtx.com |
Associate Director, Translational Research |
|
Boston, MA, US |
|
| Caitlyn Harvey |
cha****@myeloidtx.com
|
myeloidtx.com |
Senior Director CMC |
|
Gloucester, MA, US |
|
| Darren Braccia |
dbr*****@myeloidtx.com
|
myeloidtx.com |
|
|
Boston, Massachusetts, United States |
|
| Hugh Cole |
hco**@jouncetx.com
|
Jounce Therapeutics, Inc. |
|
Biotechnology Research |
Milton, MA, US |
|
| Jeff Roncal |
jro****@jouncetx.com
|
Jounce Therapeutics, Inc. |
Vice President, Head of Safety and Pharmacovigilance |
Biotechnology Research |
Boston, MA, US |
|